This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

DeMarcus Ware And Wes Welker Win Big By Rallying Thousands In Support Of The Depend Players Challenge For The Great American Try On

DALLAS, July 18, 2013 /PRNewswire/ -- Depend (, the No. 1 brand in incontinence protection, announced at last night's 21st annual ESPY Awards that it's a wrap for the Depend Players Challenge – an online competition and part of The Great American Try On in which pro football stars DeMarcus Ware and Wes Welker showcased their competitive spirit and went head-to-head to earn the most online votes to win the largest of two charitable donations in their names to The V Foundation for Cancer Research. America voted and it's a touchdown for Welker. Kimberly-Clark's Depend brand will donate $50,000 in his name and $25,000 in Ware's name for a combined total donation of $75,000 to The V Foundation to fund prostate cancer research.

To view the multimedia assets associated with this release, please click: 

This marks the second year that Ware and Welker participated in The Great American Try On and that the Depend brand has supported The V Foundation. In 2012, Ware and Welker tried on the Depend Real Fit briefs under their football uniforms to highlight the brief's underwear-like look, fit and feel as well as just how active people can be while wearing them. Since 2012, the Depend brand and Kimberly-Clark have donated $325,000 to The V Foundation.

"Just as I predicted, I crushed DeMarcus in the Depend Players Challenge. America definitely had my back on this one and I appreciate everyone's votes," said Welker.  "I'm so honored that Depend will donate $50,000 to The V Foundation on my behalf."

The V Foundation is a charitable organization dedicated to saving lives by helping to fund critical cancer research, including prostate cancer, a leading cause of bladder control issues in men.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs